SEC Hits Biotech Investor With Market Manipulation Suit
Biotechnology financier David Blech, who pled guilty Wednesday to securities fraud for manipulating the stock prices of two biotech companies, will now have to face off with the U.S. Securities and...To view the full article, register now.
Already a subscriber? Click here to view full article